National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey

被引:0
|
作者
Dursun, A. [1 ]
Bavbek, S. [2 ]
Misirligil, Z. [2 ]
Erdener, F. [3 ]
Buyukozturk, S. [4 ]
Aydin, O. [2 ]
Gemicioglu, B. [5 ]
Bayrak, P. [6 ]
Erkekol, Oner F. [1 ]
Yildirim, Z. [7 ]
Cilli, A. [8 ]
Boz, Bingol A. [9 ]
Alpaydyn, Ozgen A. [10 ]
Karakoc, G. [11 ]
Gorguner, M. [12 ]
Karakaya, G. [13 ]
Isik, R. [14 ]
Sapan, N. [15 ]
Bakirtas, A. [16 ]
机构
[1] Ataturk Chest Dis & Thorac Surg Training & Res Ho, Allergy Clin, Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Resp Med, Div Clin Immunol & Allergy, TR-06100 Ankara, Turkey
[3] Istanbul Training & Res Hosp, Dept Internal Med, Istanbul, Turkey
[4] Istanbul Univ, Istanbul Med Sch, Dept Internal Med, Div Allerg Dis, Istanbul, Turkey
[5] Istanbul Univ, Cerrahpasa Med Sch, Dept Resp Med, Istanbul, Turkey
[6] Celal Bayar Univ, Sch Med, Dept Internal Med, Div Clin Immunol & Allergy, Manisa, Turkey
[7] Fatih Univ, Sch Med, Dept Resp Med, Ankara, Turkey
[8] Akdeniz Univ, Sch Med, Dept Resp Med, TR-07058 Antalya, Turkey
[9] Akdeniz Univ, Sch Med, Dept Pediat, Div Allergy, TR-07058 Antalya, Turkey
[10] Celal Bayar Univ, Sch Med, Dept Resp Med, Manisa, Turkey
[11] Cukurova Univ, Sch Med, Dept Pediat, Div Allergy, Adana, Turkey
[12] Ataturk Univ, Sch Med, Dept Resp Med, Erzurum, Turkey
[13] Hacettepe Univ, Sch Med, Dept Resp Med, Adult Allergy Unit, Ankara, Turkey
[14] Seyhan Training & Res Hosp, Adult Allergy Unit, Adana, Turkey
[15] Uludag Univ, Sch Med, Dept Pediat, Div Allergy, Bursa, Turkey
[16] Gazi Univ, Sch Med, Dept Pediat, Div Allergy, Ankara, Turkey
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
1786
引用
收藏
页码:675 / 676
页数:2
相关论文
共 50 条
  • [1] Long-term safety and effectiveness of omalizumab in Japanese paediatric patients with severe allergic asthma: A post-marketing surveillance
    Nakamura, N.
    Kashitani, Y.
    Yoshisue, H.
    Nagasaki, M.
    Sasajima, T.
    ALLERGY, 2020, 75 : 364 - 365
  • [2] Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan
    Adachi, Mitsuru
    Kozawa, Masanari
    Yoshisue, Hajime
    Milligan, Ki Lee
    Nagasaki, Makoto
    Sasajima, Takayoshi
    Miyamoto, Terumasa
    Ohta, Ken
    RESPIRATORY MEDICINE, 2018, 141 : 56 - 63
  • [3] Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance
    Nakamura, Noriko
    Kashitani, Yuka
    Yoshisue, Hajime
    Nagasaki, Makoto
    Sasajima, Takayoshi
    ALLERGOLOGY INTERNATIONAL, 2021, 70 (03) : 319 - 326
  • [4] Real-Life Safety and Efficacy of Omalizumab in Japanese Patients with Severe Allergic Asthma Subjected to Dosing Table Revision or Expansion: A Post-Marketing Survey
    Asano, K.
    Sumi, K.
    Yoshisue, H.
    Nakamura, N.
    Nagasaki, M.
    Sasajima, T.
    Matsumoto, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Omalizumab in persistent severe bakers' asthma
    Olivieri, M.
    Biscardo, C. A.
    Turri, S.
    Perbellini, L.
    ALLERGY, 2008, 63 (06) : 790 - 791
  • [6] First Experience with Omalizumab in a Child with Severe Persistent Asthma in Turkey: Case Report
    Arga, Mustafa
    Bakirtas, Arzu
    Turktas, Ipek
    Demirsoy, M. Sadik
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2010, 30 (05): : 1764 - 1767
  • [7] Omalizumab in patients with severe persistent asthma in real life setting in Manisa, Turkey
    Havlucu, Y.
    Yorgancioglu, A.
    Kurhan, F.
    Ozdemir, L.
    Coskun, Sakar A.
    Goktalay, T.
    Yilmaz, O.
    Celik, P.
    ALLERGY, 2014, 69 : 292 - 292
  • [8] Eslicarbazepine acetate: update of post-marketing safety data
    Vieira, M.
    Gama, H.
    Graca, J.
    Costa, R.
    Sousa, R.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 773 - 773
  • [9] Interim analysis of post-marketing surveillance of omalizumab in Japan
    Ohta, Ken
    Yoshisue, Hajime
    Aoki, Yasuo
    Irokawa, Takuro
    Ishigaki, Masahide
    Adachi, Mitsuru
    Miyamoto, Terumasa
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [10] Omalizumab: A Review of its Use in Patients with Severe Persistent Allergic Asthma
    McKeage, Kate
    DRUGS, 2013, 73 (11) : 1197 - 1212